1-2 of 2 results for subject:Myopia
Librarians' tools
- Search time
- 0.408 seconds
- Solr query time
- 0.001 seconds
- Search query
- subject:Myopia
- We searched for
- subject_t:Myopia OR subject_t:Short-sightedness OR subject_ses:454745
Type
House
Session
Year
Department
Member
Primary member
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Health and Social Care, when does he expect treatment of myopia in children aged between three and 14 years through low-dose atropine eye drops to begin.
To ask the Secretary of State for Health and Social Care, when does he expect treatment of myopia in children aged between three and 14 years through low-dose atropine eye drops to begin.
The National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service in England on whether new medicines should be routinely funded based on an assessment of their costs and benefits. NICE is currently evaluating low-dose atropine eye drops for treating myopia in people aged three to 14 years old and currently expects to publish final guidance in September 2026. If recommended in final NICE guidance, the NHS would be required to fund treatment within three months of publication.
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of making atropine eye drops available on the NHS for pre-myopic children.
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of making atropine eye drops available on the NHS for pre-myopic children.
Decisions on whether medicines should be routinely funded by the National Health Service are for integrated care systems, considering relevant national guidance where available, including from the National Institute of Health and Care Excellence (NICE).
NICE is currently considering whether to develop guidance for the NHS on the use of low-dose atropine eye drops for treating myopia in children aged between three and 14 years old through its established prioritisation process.